Tenascin-cytotactin (TN-C) variants in pseudophakic/aphakic bullous keratopathy corneas

Eye

Volumn 12, Issue 4, 1998, Pages 729-734

  Maseruka, H ^a,b   Ataullah, S M ^a   Zardi, L ^c   Tullo, A B ^a   Ridgway, A E A ^a   Bonshek, R E ^a,b  

^a MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c Centro di Biotecnologie Avenzate   (Italy)

Author keywords

Adhesion; Anti adhesion; Bullous keratopathy; Extracellular matrix; Matricellular; Tenascin

Indexed keywords

GLYCOPROTEIN; TENASCIN;

ARTICLE; BASEMENT MEMBRANE; CELL ADHESION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; KERATOPATHY; PENETRATING KERATOPLASTY;

EID: 0031702849     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/eye.1998.178     Document Type: Article

References (47)

1. Lindquist TD, McGlothan JS, Rotkis WM, Chandler JW. Indications for penetrating keratoplasty 1980-1988. Cornea 1991;10:210-6.
2. The Australian cornea graft registry 1990 to 1992 report. Aust NZ J Ophthalmol 1993;21 (Suppl):1-48.
3. Lois N, Kowal VO, Cohen EJ. Indications for penetrating keratoplasty and associated procedures,1989-1995. Cornea 1997;16:623-9.
4. Kanai A, Kaufman HE. Electron microscopic studies of swollen corneal stroma. Ann Ophthalmol 1973;5:178-90.
5. Johnson DH, Bourne WM, Campbell RJ. The ultrastructure of Descemet's membrane. II. Aphakic bullous keratopathy. Arch Ophthalmol 1982;100:1948-51.
6. Eagle RC, Laibson PR, Arentsen JJ. Epithelial abnormalities in chronic corneal edema: a histopathological study. Trans Am Ophthalmol Soc 1990;87:107-24.
7. Liu GJ, Okiasaka S, Mizukawa A, Momose A. Histopathological study of pseudophakic bullous keratopathy developing after anterior chamber of iris-supported intraocular lens implantation. Jpn J Ophthalmol 1993;37:414-25.
8. Irvine AR Jr. The role of endothelium in bullous keratopathy. Cornea 1956;56:338-51.
9. McCartney MD, Robertson DP, Wood TO, McLaughlin BJ. ATPase pump site density in human dysfunctional corneal endothelium. Invest Ophthalmol Vis Sci 1987;28:1955-62.
10. Bourne MW, Nelson LR, Hodge DO. Continued endothelial cell loss ten years after lens implantation. Ophthalmology 1994;101:1014-23.
11. Quantock AJ, Meek KM, Brittain P, Ridgway AEA, Thonar EJMA. Alteration of stromal architecture and depletion of keratan sulphate proteoglycans in oedematous human corneas: histological, immunochemical and x-ray diffraction evidence. Tissue Cell 1991;23:593-606.
12. Hsu JK, Rubinfeld RS, Barry P, Jester JV. Anterior stromal puncture: immunohistochemical studies in human corneas. Arch Ophthalmol 1993;111:1057-63.
13. Ljubimov AV, Burgeson RE, Butkowski RJ, Couchman JR, Wu RR, Ninomiya Y, et al. Extracellular matrix alterations in human corneas with bullous keratopathy. Invest Ophthalmol Vis Sci 1996;37:997-1007.
14. Sage EH, Bornstein P. Extracellular proteins that modulate cell-matrix interactions: SPARC, tenascin, and thrombospondin. J Biol Chem 1991;266:14831-4.
15. Chiquet-Eherismann R. Inhibition of cell adhesion by antiadhesive molecules. Curr Opin Cell Biol 1995;7:715-9.
16. Chiquet-Eherismann R. Anti-adhesive molecules of the extracellular matrix. Curr Opin Cell Biol 1991;3:800-4.
17. Hoffman S, Dutton SL, Ernst H, Boackle MK, Everman D, Tourkin A, Loike JD. Functional characterisation of antiadhesion molecules. Perspect Dev Neurobiol 1994;2:101-10.
18. Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol 1995;130:503-6.
19. Maseruka H, Bonshek RE, Zardi L. Tenascin-C in bullous keratopathy. Vision Res 1996;36:S67.
20. Siri A, Carnemolla B, Saginati M, Leprini A, Casari G, Baralle F, Zardi L. Human tenascin: primary structure, pre-mRNA splicing patterns and localisation of the epitopes recognised by two monoclonal antibodies. Nucleic Acids Res 1991;19:525-31.
21. Borsi L, Balza E, Castellani P, Carnemolla B, Ponassi M, Querzé G, Zardi L. Cell-cycle dependent alternative splicing of the tenascin primary transcript. Cell Adhes Commun 1994;1:307-17.
22. Siri A, Allemanni G, Gaggero B, Zardi L. Different human tenascin-C variants in the extracellular matrix of cultured human fibroblasts. Biochem Cell Biol 1996;74:863-6.
23. Prieto AL, Jones FS, Cunningham BA, Crossin KL, Edelman GM. Localisation during development of alternatively-spliced forms of cytotactin by in situ hybridisation. J Cell Biol 1990;111:685-98.
24. Tucker RP. The in situ localisation of tenascin splice variants and thrombospondin 2 mRNA in the avian embryo. Development 1993;117:347-58.
25. Chiquet-Eherismann R, Matsuoka Y, Hoffer U, Spring J, Bernasconi C, Chiquet M. Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissue. Cell Regulation 1991;2:927-38.
26. Sriramarao P, Bourdon MA. A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices. Nucleic Acids Res 1993;21:163-8.
27. Klein G, Beck S, Müller CA. Tenascin is a cytoadhesive extracellular matrix component of the human hematopoeitic microenvironment. J Cell Biol 1993;123:1027-35.
28. Mighell AJ, Thompson J, Hume WJ, Markham AF, Robinson PA. Human tenascin-C: identification of a novel type III repeat in oral cancer and of novel splice variants in normal, malignant and reactive oral mucosae. Int J Cancer 1997;72:236-40.
29. Spring J, Beck K, Chiquet-Eherismann R. Two contrary functions of tenascin: dissection of the active sites by recombinant fragments. Cell 1989;59:325-34.
30. Chiquet-Eherismann R, Kalla P, Pearson CA, Beck K, Chiquet M. Tenascin interferes with fibronectin action. Cell 1988;53:383-90.
31. Murphy-Ullrich JE, Lightner VA, Aukhil I, Yan YZ, Erickson HP, Höök M. Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin. J Cell Biol 1991;115:1127-36.
32. Maseruka H, Bonshek RE, Tullo AB. Tenascin-C expression in normal, inflamed and scarred human corneas. Br J Ophthalmol 1997;81:677-82.
33. Tuori A, Virtanen I, Aine E, Uusitalo H. The expression of tenascin and fibronectin in keratoconus, scarred and normal cornea. Graefes Arch Clin Exp Ophthalmol 1997;235:222-9.
34. Hsu SM, Raine L, Fanger H. Use of avidin-biotin peroxidase complex in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
35. Mackie EJ. Tenascin in connective tissue development and pathogenesis. Perspect Dev Neurobiol 1994;2:125-32.
36. Tourkin A, Anderson T, LeRoy EC, Hoffman S. Eosinophil adhesion and maturation is modulated by laminin. Cell Adhes Commun 1993;1:161-76.
37. Julian J, Chiquet-Eherismann R, Erickson HP, Carson DD. Tenascin is induced at implantation sites in the mouse uterus and interferes with epithelial cell adhesion. Development 1994;120:661-71.
38. Schenk S, Bruckner-Tuderman L, Chiquet-Eherismann R. Dermo-epidermal separation is associated with induced tenascin expression in human skin. Br J Dermatol 1995;133:13-22.
39. 3 integrins. J Cell Sci 1993;105:1001-12.
40. Hoffman S, Crossin KL, Edelman GM. Molecular forms, binding functions, and development expression patterns of cytotactin and cytotactin-binding proteoglycan, an interactive pair of extracellular matrix molecules. J Cell Biol 1988;106:519-32.
41. Schaller MD, Borgman CA, Cobb BS, Vines RR, Reynolds AB, Parsons JT. pp125 FAK, a structurally distinctive protein-tyrosine kinase associated with focal adhesion. Proc Natl Acad Sci USA 1992;89:5192-6.
42. Ilič D, Damsky CH, Yamamoto T. Focal adhesion kinase: at the crossroads of signal transduction. J Cell Sci 1997;110:401-7.
43. Chiquet-Eherismann R, Hagios C, Schenk S. The complexity in regulating the expression of tenascins. Bioessays 1995;17:873-8.
44. Mackie EJ, Scott-Burden T, Hahn AWA, Kern F, Bernhardt J Regenass S, et al. Expression of tenascin by vascular smooth muscle cells: alterations in hypertension and stimulation by angiotensin II. Am J Pathol 1992;141:377-88.
45. Rettig WJ, Erickson HP, Albino AP, Garin-Chesa P. Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type specific signals and signaling pathways. J Cell Sci 1994;107:487-97.
46. Härkönen E, Virtanen I, Linnala A, Laitinen LL, Kinnula VL. Modulation of fibronectin and tenascin production in human bronchial epithelial cells by inflammatory cytokines in vitro. Am J Respir Cell Mol Biol 1995;13:109-15.
47. Chiquet-Eherismann R, Tannheimer M, Koch M, Brunner A, Spring J, Martin D, et al. Tenascin-C expression by fibroblasts is elevated in stressed collagen gels. J Cell Biol 1994;127:2093-101.